Skip to Main Content
ManagedCareEye.com
This website is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
  • Home
  • CE Activities
  • Faculty
  • Expert Updates
  • Outcomes
  • Resources

Retinopathy of Prematurity (ROP) –Management of an Infant Born at 30 Weeks Gestational Age in a Rural Area

December 12, 2023

FEATURING: Jeffrey Dunn, PharmD, MBA, Edward H. Wood, MD

← PayerTalkCE™Presents: Impact of An Aging US Population on Retinal Diseases   Risk of Retinal Vein Occlusion (RVO) –52-Year-Old Male with a History of Poor Adherence to Hypertension and Dyslipidemia Therapy →
  • About Impact Education, LLC
  • Contact Us (IMPACT)
  • Mailing List (IMPACT)
  • Privacy Policy

Jointly provided by

Medical Education Resources Impact Education, LLC

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.